Want to join the conversation?
$OREX 2Q15 Call: OREX has agreed to pay for the new cardiovascular outcomes trial up to estimated $210MM total cost of study. If cost exceeds this estimate, the parties will share cost generally equally. Takeda will pay the remaining cost of closing MRI study. Takeda will also pay 75% of cost of all other development activities for Contrave in US.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.